Solaris Energy Infrastructure (NYSE: SEI) will replace Catalyst Pharmaceuticals (NASD: CPRX) in the S&P SmallCap 600 effective before the open on July 15, per the index change. The note also states that Angelini Pharma S.p.A. is acquiring Catalyst, which is a supportive catalyst for CPRX holders but the snippet provides no deal size or terms.
Solaris Energy Infrastructure (NYSE: SEI) will replace Catalyst Pharmaceuticals (NASD: CPRX) in the S&P SmallCap 600 effective before the open on July 15, per the index change. The note also states that Angelini Pharma S.p.A. is acquiring Catalyst, which is a supportive catalyst for CPRX holders but the snippet provides no deal size or terms.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment